A lactylation-driven prognostic model for lung adenocarcinoma: cellular lactylation heterogeneity and immune insights
Ziheng Yang, Hui Cheng, Sheng Zhang, Fan Li, Bo Zhao · 2025
Read A lactylation-driven prognostic model for lung adenocarcinoma: cellular lactylation heterogeneity and immune insights by Ziheng Yang, Hui Cheng, Sheng Zhang, Fan Li, Bo Zhao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12775714.txt.
Description
Ziheng Yang and four co-authors build a survival predictor for lung adenocarcinoma from a newly found chemical tag on proteins, in a 2025 study. The tag, lactylation, links cell metabolism to gene control and to how immune cells act. How uneven its spread is across tumor cells was unknown.
Single-cell data showed tag levels ran high in tumor and support cells, especially in certain epithelial subgroups. Signals between cells, marker genes of highly tagged groups, and known lactylation genes together produced a candidate pool. Over a hundred model mixes were tried; a survival forest won, built on twelve genes, nine raising risk and three that lowered it. High-risk patients died sooner and had fewer immune cells move in. Lab checks largely matched the model's gene patterns. The authors offer this gene set as a step toward a tag-aware outlook for this cancer.
Catalog record
| CREATOR | Ziheng Yang, Hui Cheng, Sheng Zhang, Fan Li, Bo Zhao |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |